![]() |
市場調查報告書
商品編碼
1954593
全球器官保存市場:市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的分析以及未來預測(2026-2034)Organ Preservation Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025年全球器官保存市場規模為3.2383億美元,2026年增長至3.6865億美元,預計到2034年將達到6.8406億美元。預計在預測期內,其複合年增長率(CAGR)為8.03%。 2025年,北美以36.87%的市佔率引領全球市場。
器官保存是指從器官獲取到移植,為維持捐贈器官的活性而進行的醫療和後勤流程。其主要目標是最大限度地減少缺血性損傷,並確保移植器官發揮最佳功能。保存技術的進步使得器官保存時間更長、運輸更安全、移植效果更佳。
市場動態
市場驅動因素
推動市場成長的主要驅動因素之一是機械灌注技術的快速普及。各國監管機構對先進系統的批准進一步增強了市場需求。
2024年10月,加拿大衛生部批准了OrganOx metra系統用於肝臟移植,並計劃於2025年商業化。此外,全球移植手術數量的成長也支撐了市場需求。根據GODT/IRODaT 2023年的數據,全球實體器官移植數量增加了9-10%。在印度,2023年進行了約18,378例移植手術,與過去十年相比實現了顯著成長。
市場限制因子
儘管技術不斷進步,但高昂的資本投入和營運成本阻礙了其廣泛應用。例如,一套 OCS 心臟灌注裝置每次使用成本約為 4 萬美元,而一套可重複使用的控制台成本約為 24 萬美元。像 Paragonix Sherpa Pack 這樣的先進運輸系統每次運輸成本在 9000 美元到 17000 美元之間。這些成本限制了其普及,尤其是在發展中地區。
市場機會
保存液和氧載體的創新帶來了巨大的成長機會。例如,HEMO2life (M101) 是一種細胞外血紅素添加劑,可改善保存期間的氧合併減少缺血性損傷。臨床研究表明,該產品可改善移植器官功能並減少延遲性移植失敗 (DGF),推動了其應用。
市場挑戰
主要挑戰仍是供體器官供應有限。在美國,超過10萬名患者在等待器官移植,而2024年僅進行了48149例移植手術。儘管技術不斷進步,但供需缺口仍限制著手術數量的成長。
市場趨勢
影響市場的關鍵趨勢包括從靜態冷凍保存(SCS)轉變為低溫機械灌注(HMP)和自然溫度機械灌注(NMP)的轉變。儘管靜態冷凍保存 (SCS) 因其簡便性和成本效益而仍佔主導地位,但機械灌注技術因其能提高移植存活率並減少延遲性移植物功能恢復 (DGF) 和早期移植物衰竭等併發症而正在擴大市場佔有率。
依產品類型
保存液和培養基細分市場廣泛應用於所有器官類型,預計到 2026 年將佔最大的市場佔有率,達到 52.95%。灌注耗材和一次性用品細分市場預計到 2034 年將以 13.1% 的複合年增長率成長。
依儲存技術
靜態冷凍保存 (SCS) 細分市場預計將佔主導地位,到 2026 年將佔 52.44% 的市場佔有率。然而,自然微灌注 (NMP) 細分市場預計在預測期內將以 15.3% 的複合年增長率成長。期間。
依器官類型劃分
腎臟器官移植市場預計在2026年將以50.53%的市佔率領先,這主要得益於移植手術數量的增加以及慢性腎臟病(CKD)盛行率的上升。心臟器官移植市場預計到2034年將以13.4%的複合年增長率成長。
依最終使用者劃分
到2026年,醫院將以78.15%的市場佔有率佔主導地位,這主要得益於移植手術數量的增加以及先進灌注技術的快速普及。器官獲取組織 (OPO) 預計將以 9.2% 的複合年增長率成長。
區域分析
北美
北美地區 2025 年的市場規模將達到 1.194 億美元,預計 2026 年將達到 1.3699 億美元。憑藉其強大的移植基礎設施和對先進技術的早期應用,北美地區保持著市場領先地位。
歐洲和亞太地區
歐洲地區 2025 年的市場規模預計將達到 7,010 萬美元,複合年增長率為 7.8%。成長主要得益於移植手術數量的增加和完善的醫療保健體系。亞太地區也呈現強勁成長,這得益於人們對器官移植的認識不斷提高以及醫療保健投資的增加。
拉丁美洲和中東及非洲
預計到2025年,拉丁美洲的器官移植市場規模將達到2730萬美元,而中東及非洲的海灣合作委員會(GCC)國家在器官衰竭病例增加和移植基礎設施逐步改善的推動下,市場規模將達到980萬美元。
The global organ preservation market was valued at USD 323.83 million in 2025 and is projected to grow to USD 368.65 million in 2026, reaching USD 684.06 million by 2034, registering a CAGR of 8.03% during the forecast period. North America dominated the global market with a 36.87% share in 2025.
Organ preservation refers to the medical and logistical processes that maintain the viability of donated organs from retrieval to transplantation. The primary objective is to minimize ischemic damage and ensure optimal graft function. Advancements in preservation technologies are enabling longer storage times, safer transportation, and improved transplant outcomes.
Market Dynamics
Market Drivers
One of the key drivers accelerating market growth is the rapid adoption of machine perfusion technologies. Regulatory approvals of advanced systems across various countries are further strengthening demand.
In October 2024, Health Canada approved the OrganOx metra System for liver transplantation, with commercial launch planned in 2025. Additionally, the increasing number of transplant procedures globally supports demand. According to GODT/IRODaT 2023 data, solid-organ transplants increased by 9-10% worldwide. India recorded approximately 18,378 transplants in 2023, reflecting significant growth over the past decade.
Market Restraints
Despite technological progress, high capital investment and operating costs restrict broader adoption. For instance, the OCS Heart Perfusion Set costs approximately USD 40,000 per use, while the reusable console costs about USD 240,000. Advanced transportation systems such as Paragonix SherpaPak cost between USD 9,000 and USD 17,000 per shipment. These costs limit accessibility, especially in developing regions.
Market Opportunities
Innovation in preservation solutions and oxygen carriers presents strong growth opportunities. Products such as HEMO2life (M101), an extracellular hemoglobin additive, improve oxygenation and reduce ischemic injury during storage. Clinical studies show improved graft function and reduced delayed graft function (DGF), supporting increasing adoption.
Market Challenges
A major challenge remains limited donor organ availability. In the U.S., over 100,000 patients remain on transplant waiting lists, while 48,149 transplants were performed in 2024. The supply-demand gap continues to restrict procedural volumes despite technological advances.
Market Trends
A significant trend shaping the market is the shift from Static Cold Storage (SCS) toward Hypothermic Machine Perfusion (HMP) and Normothermic Machine Perfusion (NMP). While SCS remains dominant due to simplicity and cost-effectiveness, machine perfusion technologies are gaining share due to improved graft survival and reduced complications such as DGF and early allograft dysfunction.
By Product Type
The preservation solutions & media segment held the largest share of 52.95% in 2026, driven by widespread application across organ types. The perfusion consumables & disposables segment is projected to grow at a CAGR of 13.1% through 2034.
By Preservation Technique
The Static Cold Storage (SCS) segment dominated the market and is expected to account for 52.44% share in 2026. However, the Normothermic Machine Perfusion (NMP) segment is projected to grow at a CAGR of 15.3% during the forecast period.
By Organ Type
The kidney segment led the market with a 50.53% share in 2026, supported by high transplant volumes and rising chronic kidney disease (CKD) prevalence. The heart segment is expected to grow at 13.4% CAGR through 2034.
By End User
Hospitals dominated the market with a 78.15% share in 2026, driven by high transplant procedure volumes and rapid adoption of advanced perfusion technologies. Organ Procurement Organizations (OPOs) are projected to grow at a CAGR of 9.2%.
Regional Analysis
North America
North America accounted for USD 119.4 million in 2025 and is projected to reach USD 136.99 million in 2026, maintaining market leadership due to strong transplant infrastructure and early adoption of advanced technologies.
Europe and Asia Pacific
Europe is projected to grow at a CAGR of 7.8% and recorded USD 70.1 million in 2025. Growth is driven by rising transplant procedures and supportive healthcare frameworks. Asia Pacific is also witnessing strong growth, supported by expanding transplant awareness and healthcare investments.
Latin America and Middle East & Africa
Latin America recorded USD 27.3 million in 2025, while GCC countries in the Middle East & Africa reached USD 9.8 million in 2025, driven by increasing organ failure cases and gradual improvements in transplant infrastructure.
Competitive Landscape
The market is semi-consolidated, with key players including TransMedics, XVIVO, Terumo Corporation, Getinge AB, and Organ Recovery Systems. These companies maintain leadership through strong product portfolios, strategic acquisitions, regulatory approvals, and global expansion initiatives.
Recent developments include FDA approvals, product launches, and acquisitions such as Getinge's acquisition of Paragonix Technologies in 2024 and OrganOx's FDA approval for air transport operation in 2025.
Conclusion
The global organ preservation market is set for steady expansion from USD 323.83 million in 2025 to USD 684.06 million by 2034, driven by technological advancements in machine perfusion, rising transplant volumes, and innovation in preservation solutions. While high equipment costs and donor shortages present challenges, increasing regulatory approvals, growing awareness, and expanding healthcare infrastructure across emerging markets are expected to sustain long-term growth. As machine perfusion technologies gain momentum over traditional static cold storage, the market is poised to witness transformative advancements through 2034.
Segmentation By Product Type, Preservation Technique, Organ Type, End User, and Region
By Product Type * Preservation Solutions & Media
By Preservation Technique * Static Cold Storage (SCS)
By Organ Type * Kidney
By End User * Hospitals
By Region * North America (By Product Type, Preservation Technique, Organ Type, End User, and Country)